Correlation Between Arcellx and Relay Therapeutics
Can any of the company-specific risk be diversified away by investing in both Arcellx and Relay Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcellx and Relay Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcellx and Relay Therapeutics, you can compare the effects of market volatilities on Arcellx and Relay Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcellx with a short position of Relay Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcellx and Relay Therapeutics.
Diversification Opportunities for Arcellx and Relay Therapeutics
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Arcellx and Relay is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Arcellx and Relay Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relay Therapeutics and Arcellx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcellx are associated (or correlated) with Relay Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relay Therapeutics has no effect on the direction of Arcellx i.e., Arcellx and Relay Therapeutics go up and down completely randomly.
Pair Corralation between Arcellx and Relay Therapeutics
Given the investment horizon of 90 days Arcellx is expected to under-perform the Relay Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Arcellx is 1.4 times less risky than Relay Therapeutics. The stock trades about -0.1 of its potential returns per unit of risk. The Relay Therapeutics is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 602.00 in Relay Therapeutics on October 25, 2024 and sell it today you would lose (110.00) from holding Relay Therapeutics or give up 18.27% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Arcellx vs. Relay Therapeutics
Performance |
Timeline |
Arcellx |
Relay Therapeutics |
Arcellx and Relay Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Arcellx and Relay Therapeutics
The main advantage of trading using opposite Arcellx and Relay Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcellx position performs unexpectedly, Relay Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relay Therapeutics will offset losses from the drop in Relay Therapeutics' long position.Arcellx vs. Nuvalent | Arcellx vs. Ventyx Biosciences | Arcellx vs. Amylyx Pharmaceuticals | Arcellx vs. Day One Biopharmaceuticals |
Relay Therapeutics vs. Stoke Therapeutics | Relay Therapeutics vs. Pliant Therapeutics | Relay Therapeutics vs. Black Diamond Therapeutics | Relay Therapeutics vs. Arvinas |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |